New Highs has launched a CBG tincture.
Designed to deliver targeted relief for pain, inflammation and nausea, the tincture contains one of over 120 cannabinoids: CBG or “Cannabigerol.”
CBG is a phyto-cannabinoid that interacts with both the CB1 and CB2 receptors of the endocannabinoid system.
The recently launched CBG Tincture rounds out New Highs' collection of CBD tinctures and topicals aimed at promoting overall wellness. Golden yellow with a mild earthy flavor, New Highs' 2000mg CBG tincture is lab-tested, organic and made in the US with CO2-extracted Full Spectrum Oregon hemp.
All of New Highs tinctures include a proprietary dropper-dose system.
“Already forecasted to be the next CBD in some circles, for many consumers, CBG delivers more specific wellness benefits than CBD. Our newest addition, a 2000mg CBG tincture compliments our collection of wellness-forward CBD essentials,” says founder Sarah Remesch. “Our high-milligram tinctures are created with potent benefits at the forefront of our mission and this CBG tincture offers an option for those seeking even more targeted results.”
- Leer en Español: CBG o Cannabigerol: ¿El Próximo CBD?
Image courtesy of the company.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!